You have selected the view in English
| Descriptor English: | Drug Screening Assays, Antitumor | ||||||
| Descriptor Spanish: |
Ensayos de Selección de Medicamentos Antitumorales
| ||||||
| Descriptor Portuguese: | Ensaios de Seleção de Medicamentos Antitumorais | ||||||
| Descriptor French: | Tests de criblage d'agents antitumoraux | ||||||
| Entry term(s): |
Anti Cancer Drug Screens Anti-Cancer Drug Screen Anti-Cancer Drug Screens Anticancer Drug Sensitivity Tests Antitumor Drug Screen Antitumor Drug Screening Assays Antitumor Drug Screens Cancer Drug Test Cancer Drug Tests Drug Screen, Anti-Cancer Drug Screen, Antitumor Drug Screening Tests, Tumor Specific Drug Screening Tests, Tumor-Specific Drug Screens, Anti-Cancer Drug Screens, Antitumor Drug Test, Cancer Drug Tests, Cancer Dye Exclusion Assays, Antitumor Screen, Anti-Cancer Drug Screen, Antitumor Drug Screens, Anti-Cancer Drug Screens, Antitumor Drug Test, Cancer Drug Tests, Cancer Drug Tumor Specific Drug Screening Tests Tumor-Specific Drug Screening Tests |
||||||
| Tree number(s): |
E01.370.225.500.388 E05.200.500.388 E05.242.417 E05.337.550.200 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D004354 | ||||||
| Scope note: | Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. |
||||||
| Annotation: | IM when general; NIM when with specific antineoplastic agent (IM) |
||||||
| Allowable Qualifiers: |
CL classification EC economics ES ethics HI history IS instrumentation MT methods SN statistics & numerical data ST standards TD trends VE veterinary |
||||||
| Previous Indexing: |
Antineoplastic Agents or specific (1966-1987) Cell Line (1971-1987) Colony-Forming Units Assay (1979-1987) Drug Screening (1974-1987) Neoplasms, Experimental or specific (1966-1987) Tumor Stem Cell Assay (1984-1987) |
||||||
| Public MeSH Note: | 88 |
||||||
| History Note: | 88 |
||||||
| DeCS ID: | 22884 | ||||||
| Unique ID: | D004354 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1988/01/01 | ||||||
| Date of Entry: | 1987/05/08 | ||||||
| Revision Date: | 2015/06/22 |
-
-
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT
Diagnosis [E01]Diagnosis -
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT
Investigative Techniques [E05]Investigative Techniques -
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT
Investigative Techniques [E05]Investigative Techniques -
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT
Investigative Techniques [E05]Investigative Techniques
|
|
Drug Screening Assays, Antitumor
- Preferred
Dye Exclusion Assays, Antitumor
- Narrower
| Concept UI |
M0006844 |
| Scope note | Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. |
| Preferred term | Drug Screening Assays, Antitumor |
| Entry term(s) |
Anti Cancer Drug Screens Anti-Cancer Drug Screen Anti-Cancer Drug Screens Anticancer Drug Sensitivity Tests Antitumor Drug Screen Antitumor Drug Screening Assays Antitumor Drug Screens Cancer Drug Test Cancer Drug Tests Drug Screen, Anti-Cancer Drug Screen, Antitumor Drug Screening Tests, Tumor Specific Drug Screening Tests, Tumor-Specific Drug Screens, Anti-Cancer Drug Screens, Antitumor Drug Test, Cancer Drug Tests, Cancer Screen, Anti-Cancer Drug Screen, Antitumor Drug Screens, Anti-Cancer Drug Screens, Antitumor Drug Test, Cancer Drug Tests, Cancer Drug Tumor Specific Drug Screening Tests Tumor-Specific Drug Screening Tests |
| Concept UI |
M0006845 |
| Preferred term | Dye Exclusion Assays, Antitumor |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
